Ultragenyx aligns NICE evaluation with MHRA review of UX111 Sanfilippo gene therapy

Ultragenyx says it has aligned its NICE evaluation with the MHRA review of its UX111 Sanfilippo type A gene therapy, seeking a NICE decision near potential approval.

Detected & updated continuously · Source: Nebula